Hikal Limited
HIKAL.BO- 1D
- +0.1%
Hikal Limited in brief
Hikal Limited is a listed company in the Pharmaceutical industry, based in India. Its market value was $294 M on 20 November 2026, which makes it the 14,851st largest listed company in the world and the 1,101st largest in India on this site. In the year to Mar 2022 it had sales of $241 M and a net profit of $20 M, about 8 cents of profit for every dollar of sales. Its shares trade under the symbol HIKAL.BO (BSE).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Hikal Limited timeline
- 2001
- 📈Listed on National Stock Exchange of India as HIKALFirst day of listing in the exchange's official list.
Events of Hikal Limited from the exchanges' official lists. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Hikal Limited share price · NSE (HIKAL.NS)
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Nov 20, 2026 | 219.00 | 224.40 | 219.00 | 220.76 | -0.6% | 103,031 |
| Nov 19, 2026 | 222.00 | 223.89 | 217.21 | 222.06 | -0.5% | 110,989 |
| Nov 18, 2026 | 215.00 | 225.00 | 213.05 | 223.15 | +2.4% | 273,414 |
| Nov 17, 2026 | 215.60 | 218.79 | 215.60 | 217.94 | +0.6% | 96,272 |
| Nov 16, 2026 | 221.20 | 222.59 | 215.15 | 216.58 | -2.6% | 159,933 |
| Nov 13, 2026 | 223.99 | 226.13 | 219.53 | 222.47 | -0.5% | 159,952 |
| Nov 12, 2026 | 224.00 | 227.31 | 221.40 | 223.60 | -0.4% | 180,628 |
| Nov 11, 2026 | 225.00 | 228.68 | 224.00 | 224.52 | -0.4% | 214,301 |
| Nov 9, 2026 | 220.61 | 230.98 | 219.60 | 225.40 | +2.7% | 496,999 |
| Nov 6, 2026 | 219.40 | 220.98 | 215.27 | 219.52 | -0.6% | 173,011 |
| Nov 5, 2026 | 223.87 | 226.47 | 218.96 | 220.90 | -0.8% | 393,721 |
| Nov 4, 2026 | 213.50 | 224.24 | 210.80 | 222.63 | +3.8% | 485,156 |
| Nov 3, 2026 | 221.51 | 231.00 | 212.01 | 214.53 | -2.8% | 1.9 M |
| Nov 2, 2026 | 213.88 | 222.52 | 207.00 | 220.74 | +4.3% | 652,442 |
| Oct 30, 2026 | 205.88 | 223.70 | 204.72 | 211.58 | +3.5% | 4.1 M |
| Oct 29, 2026 | 202.21 | 206.02 | 201.61 | 204.40 | +1.1% | 147,461 |
| Oct 28, 2026 | 201.54 | 205.07 | 198.00 | 202.10 | +0.1% | 199,429 |
| Oct 27, 2026 | 193.27 | 202.80 | 193.27 | 201.83 | +3.5% | 214,586 |
| Oct 26, 2026 | 193.55 | 199.00 | 191.26 | 194.94 | +0.7% | 230,635 |
| Oct 23, 2026 | 203.19 | 204.35 | 189.45 | 193.65 | -4.7% | 403,346 |
| Oct 22, 2026 | 210.05 | 212.70 | 201.91 | 203.18 | -3.6% | 328,523 |
| Oct 21, 2026 | 215.31 | 216.84 | 207.90 | 210.76 | -3.0% | 258,296 |
| Oct 19, 2026 | 215.98 | 220.94 | 211.99 | 217.25 | +0.7% | 449,138 |
| Oct 16, 2026 | 216.47 | 216.99 | 212.75 | 215.64 | -0.4% | 197,721 |
| Oct 15, 2026 | 219.30 | 219.30 | 214.43 | 216.47 | -1.0% | 133,282 |
| Oct 14, 2026 | 214.30 | 219.00 | 211.00 | 218.68 | +2.6% | 267,708 |
| Oct 13, 2026 | 213.85 | 214.12 | 208.21 | 213.12 | +0.1% | 252,891 |
| Oct 12, 2026 | 214.00 | 216.82 | 209.20 | 212.83 | -0.4% | 375,406 |
| Oct 9, 2026 | 214.98 | 217.00 | 211.30 | 213.66 | +0.7% | 293,602 |
| Oct 8, 2026 | 226.00 | 226.00 | 211.10 | 212.21 | — | 509,857 |
Prices in INR from the National Stock Exchange of India; the last 30 trading days are listed, the chart shows up to ten years. For information only; not investment advice.
Hikal Limited share price statistics
Changes compare closing prices; volatility is the annualised standard deviation of daily returns. Prices are as published by the exchange, not adjusted for splits, bonus issues or dividends. For information only; not investment advice.
Market cap history
World rank over time
Rank in India: #544 (Jan 2020) · #517 (Jan 2021) · #466 (Jan 2022) · #534 (Dec 2022) · #652 (Jul 2023) · #714 (Jan 2024) · #772 (Mar 2026) · #1,108 (Nov 2026) · #1,108 (Nov 2026) · #1,117 (Nov 2026) · #1,117 (Nov 2026) · #1,100 (Nov 2026) · #1,101 (Nov 2026) · #1,101 (Nov 2026)
Key ratios
- P/E ratio
- 14.7×
- Price / sales
- 1.2×
- Price / book
- 2.2×
- Free cash flow yield
- —
- Net margin
- 8.3%
- Operating margin
- —
- Return on equity
- 14.9%
- Liabilities / assets
- 51.6%
Annual results
- Revenue
- $241 M
- Operating income
- —
- Net income
- $20 M
Mar-2022 ending year
Balance sheet
- Total assets
- $277 M
- Total liabilities
- $143 M
- Total equity
- $134 M
Mar-2022 ending year
Mutual funds holding Hikal Limited#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇮🇳 Tata Small Cap FundTata Asset Management | 3.30 M | $7 M | — | 0.59% | no change | Oct 31, 2026 |
| 🇺🇸 Emerging Markets Core Equity 2 PortfolioDimensional Fund Advisors LP | 337,129 | $1 M | — | <0.01% | −1.6% | Jul 31, 2026 |
| 🇺🇸 Dimensional Emerging Markets Value FundDimensional Fund Advisors LP | 204,639 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 The Emerging Markets Small Cap SeriesDimensional Fund Advisors LP | 152,071 | $0 M | — | 0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Avantis Emerging Markets Equity ETFAmerican Century ETF Trust | 65,233 | $0 M | — | <0.01% | no change | May 31, 2026 |
| 🇺🇸 State Street SPDR S&P Emerging Markets Small Cap ETFSSGA Funds Management, Inc. | 35,044 | $0 M | — | 0.01% | −17% | Jun 30, 2026 |
| 🇺🇸 World ex U.S. Core Equity PortfolioDimensional Fund Advisors LP | 13,133 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Dimensional Emerging Core Equity Market ETFDimensional Fund Advisors LP | 9,944 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 World ex U.S. Targeted Value PortfolioDimensional Fund Advisors LP | 9,005 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 State Street SPDR S&P Emerging Asia Pacific ETFSSGA Funds Management, Inc. | 8,360 | $0 M | — | <0.01% | +7.7% | Jun 30, 2026 |
| 🇺🇸 Avantis Emerging Markets Equity FundAmerican Century ETF Trust | 6,930 | $0 M | — | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Emerging Markets Targeted Value PortfolioDimensional Fund Advisors LP | 4,944 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Dimensional Emerging Markets Core Equity 2 ETFDimensional Fund Advisors LP | 3,879 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Avantis Emerging Markets Small Cap Equity ETFAmerican Century ETF Trust | 1,877 | $0 M | — | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Avantis Emerging Markets ex-China Equity ETFAmerican Century ETF Trust | 366 | $0 M | — | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Emerging Markets Social Core Equity PortfolioDimensional Fund Advisors LP | 1 | $0 M | — | <0.01% | −100% | Jul 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Oct 31, 2026. The 16 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
How Hikal Limited compares in Pharmaceutical
- Market cap$294 M · higher than 28% of 393
- Revenue$241 M · higher than 33% of 324
- Net margin8.3% · higher than 49% of 313
- P/E ratio14.7× · lower than 71% of 172
- Price / sales1.2× · lower than 79% of 219
- Price / book2.2× · lower than 50% of 207
Peer comparison · Pharmaceutical
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Hikal Limited🇮🇳 | $294 M | 14.7× | 8.3% | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Amgen Inc.🇺🇸 | $249.2 B | 26.5× | 24.1% | +9.9% |
| AstraZeneca PLC🇬🇧 | $242.6 B | 23.7× | 17.4% | +8.6% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
Sources and freshness
- Market cap:
- Nov 20, 2026
- Annual results:
- Mar-2022 ending year
- Balance sheet:
- Mar-2022 ending year
- Profile updated:
- Nov 21, 2026
Figures from Market data, value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Hikal Limited? Verify and update this profile — free
Show Hikal Limited's ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.